ReviewDeutsches Arzteblatt international2026
Fractures in Patients With Hip and Knee Prostheses: Epidemiology, Diagnosis, and Treatment.
Review in Deutsches Arzteblatt international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFractures in patients with hip or knee prostheses (periprosthetic fractures, PPF) are rare but clinically significant complications whose absolute number is steadily increasing as implantation rates rise. In Germany, approximately 200 000 hip and 170 000 knee joints are primarily replaced each year: PPFs account for approximately 15% of all revisions of hip surgery and 3% of all revisions of knee surgery.
methodsThis review is based on publications retrieved by a selective search in the PubMed/MEDLINE and Google Scholar databases up to December 2025. Registry analyses, meta-analyses, systematic reviews, and clinical trials were included.
resultsKey risk factors for PPF are advanced age (OR 1.4-1.7), female sex (OR 1.6-2.1), and osteoporosis as the overarching risk modifier. The 1-year mortality rate of 11-24% is comparable to that after fractures around the hip joint. History-taking and physical examination serve not only to assess fracture morphology but also to rule out implant loosening and low-grade infection. Most of the available evidence on treatment is derived from retrospective cohort and registry studies. The choice of treatment is mainly determined by implant stability: if the implant is stable, angle-stable osteosynthesis is performed; if it is loose, it must be replaced. The goal of surgery is a reconstruction that is stable under full weight-bearing, so that early functional mobilization can ensue and secondary complications can thereby be avoided.
conclusionInterdisciplinary treatment planning for the early resumption of function, along with low-threshold osteoporosis screening in the presence of risk factors, are key strategies for lowering mortality and preventing further fractures.
Identifiers
42452842What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.